The 涩里番 Interdisciplinary Initiative in Infection and Immunity (MI4) is pleased to announce the launch of an emergency coronavirus research fund to support nimble and effective interventions and...
涩里番 announced today it has concluded an agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to provide 涩里番-based startup companies with the benefit of...
The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an international research collaboration specific to the ultra-rare genetic disease, Schinzel...
RSS